Terms: = Thyroid cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
59 results:
1. Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment.
Ren Z; Yang K; Zhu L; Yin D; Zhou Y
Int Immunopharmacol; 2024 May; 132():111934. PubMed ID: 38574701
[TBL] [Abstract] [Full Text] [Related]
2. Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma.
Li S; Chen Z; Liu M; Li L; Cai W; Lian ZX; Guan H; Xu B
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38214937
[TBL] [Abstract] [Full Text] [Related]
3. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
[TBL] [Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor inhibitors promote antitumor responses via tumor microenvironment immunosuppression in advanced colorectal cancer.
Hamada Y; Tanoue K; Kita Y; Tanabe K; Hokonohara K; Wada M; Hozaka Y; Oi H; Nakayama C; Higashi M; Arigami T; Mori S; Ohtsuka T
Scand J Gastroenterol; 2023; 58(9):1009-1020. PubMed ID: 36987919
[TBL] [Abstract] [Full Text] [Related]
5. Spontaneous Murine Model of Anaplastic thyroid cancer.
Yan H; Ma Y; Zhou X; He Y; Liu Y; Caulin C; Wang L; Xu H; Luo H
J Vis Exp; 2023 Feb; (192):. PubMed ID: 36804915
[TBL] [Abstract] [Full Text] [Related]
6. Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Mukherjee S; Dey P; Gupta R; Radotra B; Sachdeva N; Sood A; Bhadada SK; Bhansali A
Front Endocrinol (Lausanne); 2022; 13():931647. PubMed ID: 36518249
[TBL] [Abstract] [Full Text] [Related]
7. Effect of FOXP2 transcription factor on immune infiltration of thyroid cancer and its potential clinical value.
Xu L; Yang Z; Zhao Q; Feng H; Kuang J; Liu Z; Chen L; Zhan L; Yan J; Cai W; Qiu W
Front Immunol; 2022; 13():982812. PubMed ID: 36203616
[TBL] [Abstract] [Full Text] [Related]
8. Expression of foxp3 and TLR4 in human papillary thyroid carcinoma and its clinical significance.
Xin J; Fu H; Zhang J; Zou H; Li Q; Yang W; Sun H
Histol Histopathol; 2023 Mar; 38(3):339-347. PubMed ID: 36165427
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Analysis of Prognostic and immune infiltrates for FOXPs Transcription Factors in Human Breast cancer.
Yi J; Tan S; Zeng Y; Zou L; Zeng J; Zhang C; Liu L; Fan P
Sci Rep; 2022 May; 12(1):8896. PubMed ID: 35614183
[TBL] [Abstract] [Full Text] [Related]
10. The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of cancer.
Achilla C; Papavramidis T; Angelis L; Chatzikyriakidou A
Anticancer Res; 2022 May; 42(5):2261-2276. PubMed ID: 35489753
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of Rap1GAP Expression Activates the TGF-
Yan Z; Yangyanqiu W; Shuwen H; Jing M; Haihong L; Gong C; Yin J; Qing Z; Weili G
Biomed Res Int; 2021; 2021():6840642. PubMed ID: 34840979
[TBL] [Abstract] [Full Text] [Related]
12. Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of thyroid cancer.
Bertol BC; Bales ES; Calhoun JD; Mayberry A; Ledezma ML; Sams SB; Orlicky DJ; Donadi EA; Haugen BR; French JD
Thyroid; 2022 Feb; 32(2):153-163. PubMed ID: 34641722
[No Abstract] [Full Text] [Related]
13. p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With thyroid cancer and Autoimmunity.
Arena A; Stigliano A; Belcastro E; Giorda E; Rosado MM; Grossi A; Assenza MR; Moretti F; Fierabracci A
Front Immunol; 2021; 12():728381. PubMed ID: 34539667
[TBL] [Abstract] [Full Text] [Related]
14. The emerging role of transcription factor foxp3 in thyroid cancer.
Gong Z; Jia H; Xue L; Li D; Zeng X; Wei M; Liu Z; Tong MCF; Chen GG
Rev Endocr Metab Disord; 2022 Jun; 23(3):421-429. PubMed ID: 34463908
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Significant Genes and Pathways in Acute Pancreatitis via Bioinformatical Analysis.
Ji R; Chen Y; Chen W; Wang Y; Gong F; Huang S; Xie R; Zhong M; Liu Z; Yang Z; Fei J; Mao E; Chen E
Dig Dis Sci; 2021 Sep; 66(9):3045-3053. PubMed ID: 32960383
[TBL] [Abstract] [Full Text] [Related]
16. Mechanisms of the Impact of Hashimoto thyroiditis on Papillary thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological characterization and prognostic implication of foxp3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
[TBL] [Abstract] [Full Text] [Related]
18. Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Zhao N; Liu X; Wu C; Liu Y; Zhao X; He X
J Int Med Res; 2020 Apr; 48(4):300060520919222. PubMed ID: 32314639
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer.
Li W; Xu M; Li Y; Huang Z; Zhou J; Zhao Q; Le K; Dong F; Wan C; Yi P
J Transl Med; 2020 Feb; 18(1):92. PubMed ID: 32070368
[TBL] [Abstract] [Full Text] [Related]
20. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.
Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J
APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667
[TBL] [Abstract] [Full Text] [Related]
[Next]
